Biotechnology News

July 23, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Head-to-Head Study Comparing Navidea’s AZD4694 to the Gold Standard for Imaging Beta Amyloid Protein Deposits Presented at Alzheimer's Association International Conference

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets Biotech Corporate Access Day on July 31, 2012, in Boston. In addition, Infinity will be participating in the...

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Cancer Index by Mentor Capital (MNTR) is up 29% for 2012 YTD vs 12% for NASDAQ YTD. Immunocellular Therapeutics (IMUC) leads the Index. MNTR is up 372% in 2012 YTD.

July 23, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the issuance of patents 8,207,233 and 8,207,234 by the U.S. Patent and Trademark...

July 23, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. has retained Australia Biologics Pty. Ltd. as a regulatory consultant to develop a roadmap for human clinical studies of its FluCide(tm) anti-influenza drug candidate in Australia

July 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that the company has sought leave to file counterclaims against Intelligent Bio-Systems, Inc. (IBS) and Qiagen NV, which recently acquired IBS, in response to the patent...

July 23, 2012

JERUSALEM--(BUSINESS WIRE)--Agriculture relies heavily on the use of pesticides in order to maximise crop yield. However, the widespread use of chemical pesticides has resulted in severe environmental pollution, and many pathogens are developing...

July 23, 2012

AUSTIN, Texas and OKLAHOMA CITY--(BUSINESS WIRE)--Biopharmaceutical company Caisson Biotech's $100 million deal with Novo Nordisk, global diabetes care leader, promoted appointment of biotech veteran Glenn Nedwin, PhD, as new Caisson president...

July 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced that CEO Frank Reynolds is scheduled to...

July 23, 2012

NEW YORK & PETACH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC:BCLI) announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating...

July 22, 2012

WASHINGTON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the STARTMRK study – the longest double-blind Phase III non-inferiority study evaluating an integrase inhibitor...

July 20, 2012

HENDERSON, Nev. & WESTMINSTER, Colo.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that Spectrum has provided an additional extension of the...

July 20, 2012

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says today’s Food and Drug Administration approval of Onyx’s Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options.

July 20, 2012

TIGARD, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Pink Sheets:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended...

July 20, 2012

LAKE ZURICH, Ill. & BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Kabi and Fenwal Inc. announced today a definitive agreement for Fresenius Kabi to acquire Fenwal.

July 20, 2012

WASHINGTON--(BUSINESS WIRE)--Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the Fostering Innovation Act, to update SEC filing status classifications for public companies.

July 20, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis™ (carfilzomib).

July 20, 2012

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company and Takeda announce postive CHMP opinion for conditional approval of brentuximab vedotin in Europe

July 20, 2012

GAINESVILLE, Fla. & UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation and Exactech to Partner in North America on Comprehensive Medical Education Programs to Treat the Continuum of Shoulder and Knee Repair

July 20, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, has received a positive...

July 20, 2012

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda and Millennium: The Takeda Oncology Company announce positive CHMP opinion for conditional approval of brentuximab vedotin in Europe

July 20, 2012

WASHINGTON, D.C.--(BUSINESS WIRE)--New initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), announced at the HIV Functional Cure Symposium in Washington DC, preceding the international AIDS conference, th

July 20, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions recommended by the...

July 19, 2012

ST. LOUIS--(BUSINESS WIRE)--PKS Online, Certara's hosted software solution to support compliant PK/PD analysis workflows, has been selected as the PK/PD data management solution of choice by a Top 5 Global Pharma company.

July 19, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2012 financial results will be released on Thursday, July 26, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s...

July 19, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--BRISK-FL Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Does Not Meet Overall Survival Primary Endpoint

July 19, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a...

July 19, 2012

ROCHESTER, Minn.--(BUSINESS WIRE)--Here are highlights from the July issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required....

July 19, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) will release its second quarter 2012 financial results on Thursday, August 2, 2012, after the markets close. The announcement will be followed by a live webcast at 5:00 p...

July 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2012. The Company will host a conference call and webcast today at 5:00 p.m. ET (details below)....

July 19, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, July 26, 2012, to discuss the company’s financial results for the first quarter of fiscal 2013. Management will review...

July 19, 2012

BEDFORD, Mass--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2012 financial results after the close of the market on Wednesday, August 1, 2012. The company plans to hold a...

July 19, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's "2012 CRO Quality Benchmarking - Phase I Service Providers" profiles the clinical pharmacology services of 12 Phase I CROs. The report also ranks attributes that drive vendor selection.

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems presents data on hemostasis monitoring at AACC 2012. T2Hemostasis offers rapid and direct monitoring plus measurement of anti-platelet drug effectiveness.

July 19, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces it has signed a binding...

July 19, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (Nasdaq: DARA) announced today the appointment of Stephen O. Jaeger to the DARA board of directors. Mr. Jaeger has served on the boards of a variety of private and public companies across the...

July 19, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx® Receives North American Product Leadership Award in the Molecular Diagnostics Market from Frost & Sullivan. Test for Cervical Cancer Described as the “Gold Standard for Gynecological Care."

July 19, 2012

LONDON--(BUSINESS WIRE)--New "Research Report on Chinese Chemosynthetic Polypeptide Drug Industry, 2012" worked out by China Research and Intelligence has been recently published by Market Publishers Ltd.

July 19, 2012

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Pfizer announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/...

July 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of fibromyalgia, Eli Lilly/Boehringer Ingelheim’s Cymbalta was...

July 19, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--New SEEDS supplier added to Premier’s high risk OBGYN specialty products portfolio

July 19, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus to release Q2 2012 results on August 2.

July 19, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--First Patient Enrolled for Dual-Site Physician-IND Study at University of Texas Health Sciences Center at San Antonio and Scott and White Texas A&M

July 19, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. announced today that an $8.5 million milestone was achieved in its collaboration with Amgen. The milestone was achieved after Amgen reached a pre-defined patient enrollment level

July 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended June 30, 2012 before the U.S. financial markets open on Thursday, July 26,...